Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RWJ‑333369 as Adjunctive Therapy in Subjects with Partial Onset Seizures Followed by an Open-Label Extension Study
Principal Investigator: William L. Bell, M.D.
Multi-site, randomized, double-blind, Add-on therapy for refractory partial epilepsy RWJ-333369
Inclusion Criteria: Partial onset epilepsy patients/age 16 and older/refractory to at least 1 AED/ currently treating with no more than 2 AEDs/ having at least 3 seizures per month.
Epilepsy Active Closed for Enrollment
Contact: Nancy Buchheimer
336-716-3961
nbuchhe@wfubmc.edu
Sponsor: Johnson and Johnson - Active Closed for Enrollment